Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 17, 2025 10:01 ET | Source: Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research Reacts to the Announcement of aTyr Pharma’s Phase 3 Clinical Trial Results

Foundation for Sarcoidosis Research acknowledges results of aTyr Pharma’s Phase 3 trial of efzofitimod in pulmonary sarcoidosis.
August 11, 2025 12:30 ET | Source: Custom Market Insights

[Latest] Global High Flow Nasal Cannula Market Size/Share Worth USD 5.9 Billion by 2034 at a 5.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “High Flow Nasal Cannula Market Size, Trends and Insights By Product Type (Single...
August 07, 2025 09:34 ET | Source: Spherix Global Insights

Rheumatologists Eagerly Anticipate Pipeline Advancements in Idiopathic Inflammatory Myopathies to Address Deep Unmet Need, According to Spherix Global Insights

EXTON, PA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Despite recent increased use of intravenous immunoglobulin (IVIg) and biologics, the majority of patients with idiopathic inflammatory myopathies...
July 23, 2025 04:30 ET | Source: Custom Market Insights

[Latest] Global Inferior Vena Cava IVC Filter Market Size/Share Worth USD 2,094.10 Million by 2034 at a 8.88% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)

Austin, TX, USA, July 23, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Inferior Vena Cava IVC Filter Market Size, Trends and Insights By Product Type...
April 02, 2025 07:54 ET | Source: Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research Joins with Walgreens, Cedars-Sinai to Provide Foothill Unity with Free N95 Masks to Protect Residence Cleaning Up from the Recent Los Angeles Wildfires

Foundation for Sarcoidosis Research joins with Walgreens, Cedars-Sinai, and Foothill Unity to provide LA area free N95 masks to protect lung health.
March 24, 2025 07:00 ET | Source: Lungpacer Medical USA Inc.

Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer

Lungpacer Medical Appoints Medical Device and Healthcare Industry Veteran with 20 Years of Experience as CCO
March 18, 2025 08:30 ET | Source: AccuStem Sciences, Inc.

AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening Test

AccuStem pursuing strategic commercialization plan intending to launch the MSC test in the US in 2026 LONDON and PHOENIX, Ariz., March 18, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB:...
March 10, 2025 07:00 ET | Source: Lungpacer Medical USA Inc.

Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial

Lungpacer Medical is excited to announce approval of an Investigational Device Exemption (IDE) from the U.S. FDA for the STARI clinical study.
February 20, 2025 07:00 ET | Source: Lungpacer Medical USA Inc.

Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation

Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation
February 03, 2025 11:30 ET | Source: Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research (FSR) Announces $300,000 in Grant Funding to Improve Diagnosis and Treatment of Sarcoidosis

FSR increases funding to support sarcoidosis research